Clinical Laserthermia Systems AB (publ)
The answer first
Does Clinical Laserthermia Systems beat the market?
No, Clinical Laserthermia Systems has not beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 14% of Nordic stocks
- Quality60
- Value24
- Trend8
No. 152 of 195 in healthcare
Max for seven days
Follow Clinical Laserthermia Systems with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 20 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about Clinical Laserthermia Systems
Your first answer is free, no account needed.
Do you own Clinical Laserthermia Systems, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with Clinical Laserthermia Systems and a few more. Free, no card.
Super Stock+46.4%In short
- Clinical Laserthermia Systems has fallen 76.4% over the past year, including dividends.
- Overall, Clinical Laserthermia Systems ranks better than 14% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 98.7%. The price is 99.9% below its peak now.
What do analysts think of Clinical Laserthermia Systems?
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 14% of Nordic stocks.
No. 152 of 195 in healthcare
Medium An average company: the accounts are neither especially strong nor weak.
No. 107 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity0.01
- Asset turnoverSales divided by everything the company owns0.19
- Return on equityProfit divided by equity−82.6%
- Cash conversionOperating cash flow divided by profit–
The ranking is built on equity ratio, ROA and how steadily profit grows.
Low High price: buyers pay a lot today, often because they expect growth.
No. 87 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50
- P/BPrice divided by equity1.0
- P/SPrice divided by sales3.8
- P/EPrice divided by earningsnegative earnings
- P/CFPrice divided by operating cash flownegative earnings
The ranking is built on P/E, P/B and P/S.
Low Headwind in the share price: it has done worse than most over the last year.
No. 162 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months−14.2%
- 6 months−61.1%
- 9 months−66.9%
- 12 months−76.4%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
About Clinical Laserthermia Systems
Clinical Laserthermia Systems AB (publ) is a company in healthcare, listed on Nasdaq Stockholm. By market value, Clinical Laserthermia Systems is number 108 of 137 companies in healthcare on Nasdaq Stockholm. Clinical Laserthermia Systems has not paid a dividend in the past twelve months. Of the three measures in the ranking, Clinical Laserthermia Systems is strongest on quality, better than 60% of Nordic stocks. The share trades in SEK. It has around 13 employees.
Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers that provides multiple options to control treatment. In addition, it offers various gauge laser applicators and introducers, as well as provides temperature and treatment monitoring devices. The company has a strategic partnership with ClearPoint Neuro Inc. for the development of ClearPoint Prism, a Neuro Laser Therapy System.


See the full analysis of Clinical Laserthermia Systems.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card